Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zosano Pharma Corp.

www.zosanopharma.com

Latest From Broncus Technologies Inc.

U.S. Approval, Sales Milestones Could Double PneumRx Price For BTG

Contingency payments based on regulatory and sales milestones for lead emphysema product RePneu could double the price BTG pays for U.S. biotech PneumRx, the latest addition to the United Kingdom company’s interventional medicines business.

Medical Device Business Strategies

Medical Device Deals Update, June/July 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device

Deals Shaping The Medical Industry, June 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

News In Brief

DaVita buys HealthCare Partners. Boston Scientific/Philips imaging collaboration. More news briefs.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Transdermal
    • Vaccines
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Zosano Pharma Inc.
  • Macroflux Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Zosano Pharma Corp.
  • Senior Management
  • Konstantinos Alataris, PhD, Pres. & CEO
    Winnie W Tso, CFO
    Donald Kellerman, PharmD, VP, Clinical Dev and Medical Affairs
    Hayley Lewis, VP, RA and Quality
    Eric Scharin, VP, Ops & Engineering
    Georgia Erbez, CBO
  • Contact Info
  • Zosano Pharma Corp.
    Phone: (510) 745-1200
    34790 Ardentech Ct.
    Fremont, CA 94555
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register